Charlotte Robinson

DocwireNews

Drug-induced acute interstitial nephritis (DI-AIN) is a common cause of acute kidney injury. The standard treatment is corticosteroid therapy (CS) and withdrawal of the problem-causing drug, but even with treatment, up to 50% of patients do not fully recover kidney function.Fernando Caravaca-Font&aacute;n and other researchers conducted a retrospective, observational study to develop and validate a predictive nomogram to assess the probability of complete recovery (CR) of kidney function at 6 months after treatment for DI-AIN. Their findings were presented at the 61st European Renal Association Congress.The dataset was divided randomly into a training group (n=64) and a validation group (n=64). The team used least absolute shrinkage and selection operator (LASSO) regression to screen the main predictors of CR (serum creatinine value &lt;25% of the last value before DI-AIN) and to build the nomogram. They assessed the nomogram&rsquo;s accuracy using discrimination and risk calibration in both sets.The study included 224 patients with DI-AIN who were treated with CS between 1996 and 2023. Median age of participants was 70 years (interquartile range, 57-76 years); 115 patients (51%) were male. At 6 months after treatment with CS, 51 (31%) patients in the training group and 19 (32%) in the validation group achieved CR.LASSO variables used to build the nomogram included age, gender, degree of interstitial fibrosis, and time to CS initiation. The area under the curve (AUC) of the nomogram was 0.809 (95% CI, 0.721-0.880), demonstrating good discrimination. The AUC after 1000 instances of bootstrap self-sampling for validation was 0.837 (95% CI, 0.705-0.931), indicating good predictive stability. Predicted outcomes aligned with observations, and decision curve and clinical impact curve analyses suggested clinical benefit.Source: Caravaca-Font&aacute;n F, Praga M, Fern&aacute;ndez-Ju&aacute;rez G. <a href="https://doi.org/10.1093/ndt/gfae069.1309" target="_blank" rel="noopener">Development and validation of a nomogram for predicting complete kidney function recovery after drug-induced acute interstitial nephritis.</a> Abstract #1347. Presented at the 61st European Renal Association Congress; May 23-26, 2024; Stockholm, Sweden.

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Nomogram to Predict Kidney Function Recovery After DI-AIN

ERA Congress 2024

Researchers developed a predictive nomogram to assess the probability of complete recovery of kidney function after treatment for drug-induced acute interstitial nephritis.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe